Influence of PET/CT-introduction on PET scanning frequency and indications: Results of a multicenter study

NuklearMedizin

Volumn 46, Issue 2, 2007, Pages 57-64

  Stergar, Hrvoje ^a   Bockisch, A ^a   Eschmann, S M ^b   Krause, B J ^c   Rodel R ^d   Tiling, R ^e   Weckesser, M ^f  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Computed tomography; Diagnostic imaging; PET CT; Positron emission tomography

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; FLUOROETHYLTYROSINE F 18; GALLIUM 68; IODINE 124; METHIONINE C 11; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BONE SCINTISCANNING; BRAIN SCINTISCANNING; CANCER SCINTISCANNING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; POSITRON EMISSION TOMOGRAPHY; UNIVERSITY HOSPITAL; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; GERMANY; MULTICENTER STUDY; NEOPLASM; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; STATISTICS; WHOLE BODY IMAGING; WHOLE BODY RADIATION;

GERMANY; HOSPITALS, UNIVERSITY; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; WHOLE-BODY IRRADIATION;

EID: 34247270771     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1621024     Document Type: Article

References (34)

1. Antoch G, Freudenberg LS, Stattaus J et al. Whole-body positron emission tomography-CT: optimized CT using oral and IV contrast materials. AJR Am J Roentgenol 2002; 179: 1555-1560.
2. Antoch G, Kanja J, Bauer S et al. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors. J Nucl Med 2004; 45: 357-365.
3. Antoch G, Saoudi N, Kuehl H et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004; 22: 4357-4368.
4. Antoch G, Stattaus J, Nemat AT et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229: 526-533.
5. Baks T, Cademartiri F, Moelker AD et al. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. J Am Coll Cardiol 2006; 48: 144-152.
6. Bar-Sever Z, Keidar Z, Ben-Barak A et al. The incremental value of (18)F-FDG PET/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging 2006; Epub ahead of print
7. Bar-Shalom R, Guralnik, Tsalic M L et al. The additional value of PET/CT over PET in FDG imaging of oesophageal cancer. Eur J Nucl Med Mol Imaging 2005; 32: 918-924.
8. Bar-Shalom R, Yefremov N, Guralnik L et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003; 44: 1200-1209.
9. 18F-FDG PET/CT. J Nucl Med 2005; 46: 429-435.
10. 18F-FDG PET/CT in the presence of truncation artifacts. J Nucl Med 2006; 47: 91-99.
11. 18F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rows. Eur J Nucl Med Mol Imaging 2005; 32: 1429-1439.
12. Beyer T, Townsend DW, Brun T et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-1379.
13. Bockisch A, Beyer T, Antoch G et al. Positron emission tomography/computed tomography-imaging protocols, artifacts, and pitfalls. Mol Imaging Biol 2004; 6: 188-199.
14. th, Blodgett TM, Zimmer LA et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 2005; 235: 580-586.
15. 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003; 44: 1797-1803.
16. 99mTc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 2002; 43: 1012-1017.
17. 123I-MIBG SPECT/CT. J Nucl Med 2006; 47: 1635-1642.
18. Franzius C, Juergens KU, Schober O. Is PET/CT necessary in paediatric oncology? For. Eur J Nucl Med Mol Imaging 2006; 33: 960-965.
19. Freudenberg LS, Antoch G, Schutt P et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2004; 31: 325-329.
20. 124I-PET/ CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004; 14: 2092-2098.
21. Groves AM, Kayani I, Dickson JC et al. Oral contrast medium in PET/CT: should you or shouldn't you? Eur J Nucl Med Mol Imaging 2005; 32: 1160-1166.
22. Hermann S, Wormanns D, Pixberg M et al. Staging in childhood lymphoma: differences between FDG-PET and CT. Nuklearmedizin 2005; 44: 1-7.
23. Hunold P, Brandt-Mainz K, Freudenberg L et al. Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging - comparison of the late enhancement technique with positron emission tomography. Röfo 2002; 174: 867-873.
24. Juergens KU, Weckesser M, Stegger L et al. Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules? Eur Radiol 2006; 16: 1131-1137.
25. Khan MA, Combs CS, Brunt EM et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000; 32: 792-797.
26. 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 2003; 30: 1467-1472.
27. 18F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2003; 41: 1341-1348.
28. Leber AW, Knez A, von Ziegler F et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 2005; 46: 147-154.
29. 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease. Ann NY Acad Sci 2006;1072: 379-385.
30. Nakamoto Y, Chin BB, Kraitchman DL et al. Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies. Radiology 2003; 227: 817-824.
31. Namdar M, Hany TF, Koepfli P et al. Integrated PET/CT for the assessment of coronary artery disease: a feasibility study. J Nucl Med 2005; 46: 930-935.
32. Petrowsky H, Wildbrett P, Husarik DB et al. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006; 45: 43-50.
33. rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 2001; 28: 1707-1723.
34. Shim SS, Lee KS, Kim BT et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236: 1011-1019.